Novo Nordisk A/S (NVO) Earnings Date, Estimates & Call Transcripts → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free NVO Stock Alerts $126.85 +1.06 (+0.84%) (As of 04/26/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 2Before Market OpensConfirmedActual EPS (Jan. 31) $0.71 Beat By $0.05 Consensus EPS (Jan. 31) $0.66 Get Novo Nordisk A/S Earnings AlertsEnter your email address below to receive the latest news and earnings results for NVO and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueNVO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NVO Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Novo Nordisk A/S Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:$3.32 EPSNext Year EPS Consensus Estimate: $4.09 EPSNVO Earnings Date and InformationNovo Nordisk A/S last issued its earnings data on January 31st, 2024. The reported $0.71 EPS for the quarter, beating analysts' consensus estimates of $0.66 by $0.05. The business earned $9.51 billion during the quarter, compared to analysts' expectations of $9.14 billion. Novo Nordisk A/S has generated $2.71 earnings per share over the last year ($2.71 diluted earnings per share) and currently has a price-to-earnings ratio of 46.9. Earnings for Novo Nordisk A/S are expected to grow by 23.19% in the coming year, from $3.32 to $4.09 per share. Novo Nordisk A/S has confirmed that its next quarterly earnings report will be published on Thursday, May 2nd, 2024. Novo Nordisk A/S will be holding an earnings conference call on Thursday, May 2nd at 7:00 AM Eastern. Interested parties can register for or listen to the call.. Read More Novo Nordisk A/S Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/2/2024Confirmed)------- 1/31/2024Q4 2023$0.66$0.71+$0.05$0.71$9.14 billion$9.51 billion11/2/2023Q3 2023$0.69$0.73+$0.04$0.73-$8.58 billion8/10/2023Q2 2023$0.3350$0.3150($0.02)$1.26$8.44 billion$7.93 billion 5/4/2023Q1 2023$0.3175$0.3175-$1.27$7.86 billion$7.69 billion2/1/2023Q4 2022$0.2025$0.2075+$0.0050$0.83$6.74 billion$6.60 billion11/2/2022Q3 2022$0.21$0.2150+$0.0050$0.86$6.09 billion$6.17 billion Get the Latest News and Ratings for NVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Novo Nordisk A/S and its competitors with MarketBeat's FREE daily newsletter. 8/3/2022Q2 2022$0.2175$0.21($0.0075)$0.84$5.86 billion$5.91 billion4/29/2022Q1 2022$0.2125$0.2350+$0.0225$0.94$5.82 billion$6.34 billion2/2/2022Q4 2021$0.1775$0.1825+$0.0050$0.73$5.63 billion$5.89 billion 11/2/2021Q3 2021$0.1950$1.3175+$1.1225$0.84$5.64 billion$5.65 billion 8/3/2021Q2 2021$0.19$1.3150+$1.1250$0.85$5.21 billion$5.35 billion 5/4/2021Q1 2021$0.2025$1.3625+$1.16$0.88$5.02 billion$5.48 billion Novo Nordisk A/S Earnings - Frequently Asked Questions When is Novo Nordisk A/S's earnings date? Novo Nordisk A/S has confirmed that its next quarterly earnings data will be published on Thursday, May 2nd, 2024. Learn more on NVO's earnings history. Did Novo Nordisk A/S beat their earnings estimates last quarter? In the previous quarter, Novo Nordisk A/S (NYSE:NVO) reported $0.71 earnings per share (EPS) to beat the analysts' consensus estimate of $0.66 by $0.05. Learn more on analysts' earnings estimate vs. NVO's actual earnings. How much revenue does Novo Nordisk A/S generate each year? Novo Nordisk A/S (NYSE:NVO) has a recorded annual revenue of $33.71 billion. How much profit does Novo Nordisk A/S generate each year? Novo Nordisk A/S (NYSE:NVO) has a recorded net income of $12.15 billion. NVO has generated $2.71 earnings per share over the last four quarters. What is Novo Nordisk A/S's price-to-earnings ratio? Novo Nordisk A/S (NYSE:NVO) has a trailing price-to-earnings ratio of 46.89 and a forward price-to-earnings ratio of 38.21. The price/earnings-to-growth ratio is 2.12. What is Novo Nordisk A/S's EPS forecast for next year? Novo Nordisk A/S's earnings are expected to grow from $3.32 per share to $4.09 per share in the next year, which is a 23.19% increase. More Earnings Resources from MarketBeat Related Companies: Eli Lilly and Company Earnings Results Johnson & Johnson Earnings Results Merck & Co., Inc. Earnings Results AbbVie Earnings Results AstraZeneca Earnings Results Novartis Earnings Results Abbott Laboratories Earnings Results Pfizer Earnings Results UnitedHealth Group Earnings Results Thermo Fisher Scientific Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NYSE:NVO) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Nordisk A/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
